The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
106857493 10685749 3 F 2000 20160815 20141231 20160824 EXP US-009507513-1204USA04480 MERCK 0.00 M Y 82.86000 KG 20160824 CN US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
106857493 10685749 1 PS PROPECIA FINASTERIDE 1 Oral 1 MG, UNK U 20788 1 MG FILM-COATED TABLET
106857493 10685749 2 SS PROSCAR FINASTERIDE 1 Oral 5 MG, UNK U 0 5 MG FILM-COATED TABLET
106857493 10685749 3 SS PROSCAR FINASTERIDE 1 U 0 FILM-COATED TABLET
106857493 10685749 4 SS FINASTERIDE. FINASTERIDE 1 Oral 5 MG, DAILY U 0 5 MG TABLET QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
106857493 10685749 1 Alopecia
106857493 10685749 2 Benign prostatic hyperplasia
106857493 10685749 3 Alopecia
106857493 10685749 4 Alopecia

Outcome of event

Event ID CASEID OUTC COD
106857493 10685749 HO
106857493 10685749 OT
106857493 10685749 DS

Reactions reported

Event ID CASEID DRUG REC ACT PT
106857493 10685749 Abnormal loss of weight
106857493 10685749 Acne
106857493 10685749 Actinic keratosis
106857493 10685749 Anxiety
106857493 10685749 Arthralgia
106857493 10685749 Asthenia
106857493 10685749 Astigmatism
106857493 10685749 Back disorder
106857493 10685749 Back pain
106857493 10685749 Benign prostatic hyperplasia
106857493 10685749 Cognitive disorder
106857493 10685749 Colonoscopy
106857493 10685749 Corneal scar
106857493 10685749 Decreased appetite
106857493 10685749 Depression
106857493 10685749 Diarrhoea
106857493 10685749 Drug administration error
106857493 10685749 Ejaculation disorder
106857493 10685749 Ejaculation failure
106857493 10685749 Erectile dysfunction
106857493 10685749 Essential hypertension
106857493 10685749 Haematochezia
106857493 10685749 Haemorrhoids
106857493 10685749 Hyalosis asteroid
106857493 10685749 Hypercholesterolaemia
106857493 10685749 Hypothyroidism
106857493 10685749 Infection
106857493 10685749 Intervertebral disc displacement
106857493 10685749 Libido decreased
106857493 10685749 Ligament sprain
106857493 10685749 Limb injury
106857493 10685749 Lumbar radiculopathy
106857493 10685749 Muscle spasms
106857493 10685749 Presbyopia
106857493 10685749 Prostatic specific antigen increased
106857493 10685749 Renal disorder
106857493 10685749 Rosacea
106857493 10685749 Rotator cuff syndrome
106857493 10685749 Sexual dysfunction
106857493 10685749 Tendonitis
106857493 10685749 Type 2 diabetes mellitus
106857493 10685749 Vitamin D deficiency

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
106857493 10685749 1 2000 0
106857493 10685749 2 2010 201111 0
106857493 10685749 4 20111121 0